tiprankstipranks
Amrize Ltd (AMRZ)
NYSE:AMRZ
Want to see AMRZ full AI Analyst Report?

Amrize Ltd (AMRZ) AI Stock Analysis

135 Followers

Top Page

AMRZ

Amrize Ltd

(NYSE:AMRZ)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 5.2)
Rating:67Neutral
Price Target:
$58.00
▲(0.52% Upside)
Action:Downgraded
Date:05/03/26
The score is driven primarily by solid fundamentals (healthy margins and improved leverage) and a positive earnings outlook with clear growth and margin initiatives. These positives are tempered by weakening recent free-cash-flow trends, bearish technical signals, and a relatively high P/E combined with a low dividend yield.
Positive Factors
Healthy margins
Amrize's TTM gross margin (~25.8%) and robust EBITDA margin (~23.7%) underpin durable profitability that supports reinvestment, debt reduction and shareholder programs. Margins remain near industry-competitive levels and provide operating leverage to absorb cyclicality over the next several quarters.
Negative Factors
Weakening free cash flow trend
Free cash flow has declined (TTM $1.32B vs $1.42B prior year; FCF growth -7.113) and cash conversion has softened (~66% of net income, operating coverage ~0.68). A persistent FCF weakening could constrain funding for growth capex, M&A or shareholder returns over multiple quarters if not reversed.
Read all positive and negative factors
Positive Factors
Negative Factors
Healthy margins
Amrize's TTM gross margin (~25.8%) and robust EBITDA margin (~23.7%) underpin durable profitability that supports reinvestment, debt reduction and shareholder programs. Margins remain near industry-competitive levels and provide operating leverage to absorb cyclicality over the next several quarters.
Read all positive factors

Amrize Ltd (AMRZ) vs. SPDR S&P 500 ETF (SPY)

Amrize Ltd Business Overview & Revenue Model

Company Description
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025....

Amrize Ltd Earnings Call Summary

Earnings Call Date:Feb 17, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Aug 03, 2026
Earnings Call Sentiment Positive
The call conveyed a predominantly positive outlook: Amrize reported modest full-year revenue growth, strong adjusted EBITDA ($3.0B), robust cash generation (49% conversion), significant margin expansion in Building Materials, clear progress on the ASPIRE cost-savings program, meaningful capacity expansions and a strategic, accretive acquisition (PB Materials). Management also announced a sizeable shareholder return program and provided constructive 2026 guidance (4%–6% revenue, 8%–11% EBITDA). Offsetting these positives are notable near-term challenges in the Building Envelope/residential roofing business (Q4 revenues down 11.8%, $8M warranty charge), a slight company-level Q4 revenue decline (-0.4%), seasonal Q1 headwinds, and the impact of elevated growth CapEx on free cash flow. Overall, the favorable operating momentum, margin initiatives, balance-sheet strength and constructive guidance outweigh the segment-specific softness and near-term headwinds.
Positive Updates
Full-Year Revenue and Profitability
2025 revenues increased 0.9% to $11.8 billion and adjusted EBITDA was $3.0 billion, reflecting stable full-year performance following the spin-off.
Negative Updates
Quarterly Revenue Slight Decline
Total company revenues were slightly lower in Q4, down 0.4% year-over-year, reflecting near-term softness in some end markets.
Read all updates
Q4-2025 Updates
Negative
Full-Year Revenue and Profitability
2025 revenues increased 0.9% to $11.8 billion and adjusted EBITDA was $3.0 billion, reflecting stable full-year performance following the spin-off.
Read all positive updates
Company Guidance
Amrize’s 2026 guidance targets 4–6% revenue growth and 8–11% adjusted EBITDA growth (includes the PB Materials acquisition, ~$180M revenue, closing Q1 2026), supported by higher investment (CapEx planned at $900M in 2026 vs. $788M in 2025) and the ASPIRE program (targeting 70 basis points of margin expansion in 2026 and $250M of synergies by 2028); they expect cement pricing to rise low single-digits and aggregates pricing mid single-digits (freight‑adjusted) with positive volume growth for both (cement +3.6% and aggregates +3.0% in Q4 ’25), Building Materials Q4 revenue ~$2.2B and adjusted EBITDA $705M (margin 32.6%, +60 bps), Building Envelope Q4 revenue $678M (−11.8%) with residential volumes guided flat in 2026 and commercial roofing low-single-digit volume growth, and financials underpinned by strong cash generation (2025 adjusted EBITDA $3.0B, free cash flow ≈$1.5B, cash conversion ~49%), a net leverage ratio of 1.1x (net debt ≈$3.3B), ~ $6B available liquidity, an expected effective tax rate of 21–23%, corporate costs ≈$200M, plus a $1B share repurchase program and proposed $0.44 special and $0.44 annual dividends.

Amrize Ltd Financial Statement Overview

Summary
Profitability is solid (TTM gross margin ~25.8%, EBITDA margin ~23.7%) and leverage has improved (debt-to-equity ~0.53). Offsetting this, earnings and margins are down from 2024 peaks and cash flow quality is weakening with lower free cash flow and sharply negative FCF growth (TTM FCF $1.32B; FCF growth -7.113).
Income Statement
78
Positive
Balance Sheet
74
Positive
Cash Flow
67
Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022
Income Statement
Total Revenue11.91B11.81B11.70B11.68B10.73B
Gross Profit3.02B3.03B3.07B2.77B2.47B
EBITDA2.79B2.82B3.01B2.70B2.50B
Net Income1.16B1.19B1.42B956.00M1.11B
Balance Sheet
Total Assets24.27B24.25B23.52B23.05B20.67B
Cash, Cash Equivalents and Short-Term Investments1.10B1.92B1.82B1.11B351.00M
Total Debt6.67B5.91B5.79B9.52B8.66B
Total Liabilities11.18B10.99B10.21B13.84B12.46B
Stockholders Equity13.09B13.25B13.31B9.20B8.21B
Cash Flow
Free Cash Flow1.32B1.42B1.64B1.41B1.50B
Operating Cash Flow2.17B2.21B2.28B2.04B1.99B
Investing Cash Flow-960.00M-361.00M-1.21B-2.02B-2.52B
Financing Cash Flow-715.00M-1.55B-537.00M734.00M497.00M

Amrize Ltd Risk Analysis

Amrize Ltd disclosed 1 risk factors in its most recent earnings report. Amrize Ltd reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Amrize Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$19.12B1.843.40%0.74%5.01%-67.33%
72
Outperform
$32.30B5.8725.07%0.51%-1.28%140.98%
68
Neutral
$34.01B54.2713.10%0.67%7.41%19.13%
67
Neutral
$27.91B10.79%2.52%-6.15%
66
Neutral
$1.83B15.5920.25%1.12%9.84%-12.68%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
46
Neutral
$12.08B98.671.94%24.71%-77.97%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AMRZ
Amrize Ltd
49.95
-1.53
-2.97%
CX
Cemex SAB
12.56
5.50
77.88%
MLM
Martin Marietta Materials
536.48
-22.24
-3.98%
VMC
Vulcan Materials
260.65
-5.60
-2.10%
TGLS
Tecnoglass
41.16
-42.09
-50.56%
JHX
James Hardie Industries PLC
20.76
-7.59
-26.77%

Amrize Ltd Corporate Events

DividendsShareholder Meetings
Amrize Proposes Special One-Time Dividend Ahead of AGM
Positive
Apr 14, 2026
Amrize Ltd has proposed a special one-time dividend of USD $0.44 per outstanding ordinary share, to be voted on at its 2026 Annual General Meeting scheduled for April 21, 2026. The move signals a return of excess capital to investors and may enhan...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 03, 2026